Drugmaker Merck to acquire Imago BioSciences for $1.35 bln, Health Information, ET HealthWorld


Bengaluru: Merck & Co Inc stated on Monday it will acquire most cancers drug developer Imago BioSciences for a complete fairness price of $1.35 billion.

Merck’s be offering of $36 in line with percentage in money for Imago represents just about a 107 in line with cent top rate to the corporate’s final ultimate value.

The deal for the clinical-stage biopharmaceutical corporate this is growing medication for the remedy of bone marrow-related illnesses is anticipated to shut within the first quarter of 2023, Merck stated.

Observe and connect to us on , Facebook, Linkedin, Youtube





Source link

Posted on

Leave a Reply

Your email address will not be published. Required fields are marked *